MA Liu - Vaccines. Preventing Disease and Protecting Health, 2003 - ingentaconnect.com The DNA vaccines are simple rings of DNA containing a gene encoding an antigen,
and a promoter/terminator to make the gene express in mammalian cells. They are
a prom- ising new approach for generating all types of desired immunity— ... Cited by 161 - Related articles - BL Direct - All 9 versions
MR Hilleman - Vaccine, 2003 - Elsevier Viral hepatitis B is an enigmatic disease in which the host's own immune
response to persistent viral infection may bring about host destruction through
antiviral inflammatory responses which might otherwise present as a benign ... Cited by 60 - Related articles - All 5 versions
- ►nih.gov A Facciabene, L Aurisicchio, N La Monica - The Journal of Virology, 2004 - jvi.highwire.org To characterize the induction of antigen-specific immune response mediated by
baculovirus, vectors expressing the E2 glycoprotein of hepatitis C virus or the
carcinoembryonic antigen (CEA) under the control of the cytomegalovirus ... Cited by 54 - Related articles - BL Direct - All 7 versions
G Hermanson, V Whitlow, S Parker, K Tonsky, … - Proceedings of the National Academy of Sciences of …, 2004 - National Acad Sciences DNA vaccines provide an attractive technology platform against bioterrorism
agents due to their safety record in humans and ease of construction, testing,
and manufacture. We have designed monovalent and bivalent anthrax plasmid ... Cited by 52 - Related articles - BL Direct - All 14 versions
H Jin, Y Li, Z Ma, F Zhang, Q Xie, D Gu, B … - Vaccine, 2004 - Elsevier DNA vaccination is useful for generating immune responses, particularly the
cell-mediated immune response, in a wide variety of species. However, DNA
vaccination generally induces only relatively weak responses; hence, ... Cited by 44 - Related articles - All 5 versions
S Jilek, HP Merkle, E Walter - Advanced drug delivery reviews, 2005 - Elsevier This paper provides a review of the role of dendritic cells (DC) in
microparticle-mediated immune response and the advantages of associating DNA to
microparticles in order to increase the potency of DNA vaccination in vivo. ... Cited by 39 - Related articles - All 4 versions
C Mennuni, F Calvaruso, A Facciabene, L … - International Journal of Cancer, 2005 - interscience.wiley.com The immunogenic properties of plasmid DNA and recombinant adenovirus (Ad)
encoding the carcinoembryonic antigen (CEA) were examined in mice by measuring
both the amplitude and type of immune response, and the immunogenicity of ... Cited by 34 - Related articles - BL Direct - All 3 versions
Y Eralp, X Wang, JP Wang, MF Maughan, JM … - Breast Cancer Res, 2004 - biomedcentral.com Introduction Cancer treatment options directed at specific molecular targets,
such as HER2/neu in breast cancer and c-kit in chronic myeloid leukemia and
gastrointestinal stromal sar- comas, have proven effective [1–4]. ... Cited by 33 - Related articles - View as HTML - All 12 versions
- ►jimmunol.org SE Applequist, E Rollman, MD Wareing, M … - The Journal of Immunology, 2005 - Am Assoc Immnol Improving DNA vaccination remains a fundamental goal in vaccine research.
Theoretically, this could be achieved by molecules encoded by DNA capable of
activating TLRs to mimic inflammatory responses generated by infection. ... Cited by 31 - Related articles - BL Direct - All 5 versions
